ArticleHealth science reports2026
Genetic Identification of Potential Drug Targets for Dental Caries: A Mendelian Randomization Study.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic Identification of Potential Drug Targets for Dental Caries: A Mendelian Randomization Study.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Dental caries (DC), a chronic and multifactorial disease, affects billions of people globally, posing a significant public health challenge. Despite its prevalence, the molecular mechanisms underlying DC and effective pharmacological targets remain elusive. This study leverages Mendelian randomization (MR) and large-scale genomic data to identify potential drug targets for DC. Methods: We utilized eQTL and genome-wide association studies (GWAS) data to identify genes whose expression is causally linked to DC risk. The eQTL data were extracted from the eQTLGen consortium, and the GWAS data were obtained from the IEU OpenGWAS database. We performed MR analysis using the R package TwoSampleMR and validated the results in the FinnGen cohort. We integrated phenome-wide association studies (PheWAS), gene ontology (GO), and protein-protein interaction (PPI) network construction to explore the potential roles of the identified genes. Molecular docking studies were conducted to identify potential therapeutic agents targeting TUBB. Results: We identified 32 genes whose expression is causally linked to DC risk. Further validation in the FinnGen cohort narrowed these down to nine key genes: EIF4G3, PREX1, ZFYVE19, TUBB, CBLL1-AS1, EDAR, ADRA2A, BBS10, and TCTN1. These genes were analyzed to explore their roles in dental caries. Molecular docking studies identified paclitaxel and mebendazole as potential therapeutic agents targeting TUBB, with binding energies as low as -9.2 kcal/mol, indicating strong binding affinity. Conclusion: We identified nine novel candidate drug targets for DC through a comprehensive MR approach combined with multi-omics analyses. These findings highlight the potential of these genes as therapeutic targets and provide valuable insights into the genetic basis of dental caries. The findings provide insights into the genetic basis of DC and highlight targets for future therapeutic development, though experimental validation is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.